REGISTER or Login User ID (e mail) : Password :  Forgot Password
Try eating raw foods one day a week,which help to clean the bowel and give you 'enzyme energy'.Enzyme are 'living'proteins that help to stimulate your digestive juices.  |   Apples are great for relieving constipation.  |   The mineral zinc is essential for the prevention of prostate problems.  |   Sometimes your body needs a complete break from solid foods,Choose a suitable weekday or perhaps a weekend and drink a large glass of fresh juice every two hours.You'll clear poisons and wastes from your body and feel fabulously invigorated.  |   If you suffer from indigestion,drink three or four cups of organic peppermint tea a day.  |   Bananas are rich in potassium and vitamin C,and are a wonderful convenient source of energy.Try to include bananain daily fruit intake.  |   Music can bring calm and peacefullness to anxious moments.  |   Ginger is a warming herb that stimulates the circulatory system and can prevent sudden illness.  |   Iron carries oxyzen throught the body, fights infections and produces energy from the food we eat.  |   Poor posture can create all sorts of neck and back problems,so follow the good posture and make it a habit.  |   
Search Drug (generic name) :

List of Approved Drugs

No Drug Indication Date Country Brand Company
1963 BAZEDOXIFENE ACETATE; ESTROGENS, CONJUGATED (New combination) DUAVEE is a combination of conjugated estrogens with an estrogen agonist/antagonist indicated for treatment of the following conditions in women with a uterus: ? Treatment of moderate to severe vasomotor symptoms associated with menopause. ? Prevention of postmenopausal osteoporosis. Limitation of Use: DUAVEE should be used for the shortest duration consistent with treatment goals and risks for the individual woman. 03 October 2013 US DUAVEE WYETH PHARMS PFIZER
1962 VORTIOXETINE HYDROBROMIDE (New molecular entity) BRINTELLIX is .indicated for the treatment of major depressive disorder (MDD) 30 September 2013 US BRINTELLIX TAKEDA PHARMS USA
1961 BRIMONIDINE TARTRATE (New dosage form) MIRVASO (brimonidine) topical gel, 0.33% is an alpha adrenergic agonist indicated for the topical treatment of persistent (nontransient) facial erythema of rosacea in adults 18 years of age or older. 23 August 2013 US MIRVASO GALDERMA LABS LP
1960 TOPIRAMATE (New dosage form) Trokendi XR? is an antiepileptic drug indicated for: ?Partial Onset Seizure and Primary Generalized Tonic-Clonic Seizures -initial monotherapy in patients 10 years of age and older with partial onset or primary generalized tonic-clonic seizures and adjunctive therapy in patients 6 years of age and older with partial onset or primary generalized tonic-clonic seizures. ?Lennox-Gastaut Syndrome (LGS) - adjunctive therapy in patients 6 years of age and older with seizures associated with Lennox-Gas 16 August 2013 US TROKENDI XR SUPERNUS PHARMS
1959 ENALAPRIL MALEATE (New dosage form) 1 mg/ml oral solution, Indicated for: ? treatment of hypertension in adults and children older than one month, to lower blood pressure. Lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions. 13 August 2013 US EPANED KIT SILVERGATE PHARMS
1958 DOLUTEGRAVIR SODIUM (New molecular entity) TIVICAY is a human immunodeficiency virus type 1 (HIV-1) integrase strand transfer inhibitor (INSTI) indicated in combination with other antiretroviral agents for the treatment of HIV-1 infection in adults and children aged 12 years and older and weighing at least 40 kg. 12 August 2013 US TIVICAY VIIV HLTHCARE
1957 ESOMEPRAZOLE STRONTIUM (New active ingredient) Esomeprazole strontium is a proton pump inhibitor indicated for adults for: ? Treatment of gastroesophageal reflux disease (GERD) (1.1) ? Risk reduction of NSAID-associated gastric ulcer (1.2) ? H. pylori eradication to reduce the risk of duodenal ulcer recurrence (1.3) ? Pathological hypersecretory conditions, including Zollinger-Ellison syndrome. 06 August 2013 US ESOMEPRAZOLE STRONTIUM HANMI PHARM CO LTD
1956 LEVOMILNACIPRAN HYDROCHLORIDE (New active ingredient) FETZIMA is a serotonin and norepinephrine reuptake inhibitor (SNRI) indicated for the treatment of Major Depressive Disorder (MDD). Limitation of Use: FETZIMA is not approved for the management of fibromyalgia. The efficacy and safety of FETZIMA for the management of fibromyalgia have not been established. 25 July 2013 US FETZIMA FOREST LABS INC
1955 TACROLIMUS (New dosage form) ASTAGRAF XL is a calcineurin-inhibitor immunosuppressant indicated for the prophylaxis of organ rejection in patients receiving a kidney transplant with mycophenolate mofetil (MMF) and corticosteroids, with or without basiliximab induction. Limitations of use: ? Not interchangeable with tacrolimus immediate-release capsules ? Do not use simultaneously with cyclosporine 19 July 2013 US ASTAGRAF XL ASTELLAS
1954 GOLIMUMAB SIMPONI ARIA is a tumor necrosis factor (TNF) blocker indicated for the treatment of adult patients with moderately to severely active Rheumatoid Arthritis (RA) in combination with methotrexate. 18 July 2013 US SIMPONI ARIA JANSSEN BIOTECH
Follow IHS